Linked Life Data

1383819

Source:http://linkedlifedata.com/resource/pubmed/id/1383819

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
1992-11-10
pubmed:abstractText
In 1984, the Eastern Cooperative Oncology Group began a randomized controlled clinical trial of patients with advanced (stage III or IV) diffuse mixed or diffuse large-cell lymphoma to determine whether complete-remission rates, survival, and toxicity differed when patients were treated with a chemotherapeutic regimen containing cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), as compared with a regimen containing bleomycin, doxorubicin, cyclophosphamide, vincristine, dexamethasone, methotrexate, and leucovorin (m-BACOD).
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0028-4793
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
327
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1342-9
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:1383819-Age Factors, pubmed-meshheading:1383819-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:1383819-Bleomycin, pubmed-meshheading:1383819-Cyclophosphamide, pubmed-meshheading:1383819-Dexamethasone, pubmed-meshheading:1383819-Doxorubicin, pubmed-meshheading:1383819-Drug Administration Schedule, pubmed-meshheading:1383819-Female, pubmed-meshheading:1383819-Follow-Up Studies, pubmed-meshheading:1383819-Humans, pubmed-meshheading:1383819-Leucovorin, pubmed-meshheading:1383819-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:1383819-Lymphoma, Non-Hodgkin, pubmed-meshheading:1383819-Male, pubmed-meshheading:1383819-Methotrexate, pubmed-meshheading:1383819-Middle Aged, pubmed-meshheading:1383819-Prednisone, pubmed-meshheading:1383819-Remission Induction, pubmed-meshheading:1383819-Survival Rate, pubmed-meshheading:1383819-Vincristine
pubmed:year
1992
pubmed:articleTitle
Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
pubmed:affiliation
Northwestern University Medical School, Department of Medicine, Chicago, IL 60611.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial